If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
316.80    -1.80 (-0.56%)
Bid:
317.00
Ask:
320.00
Spread: 3.00 (0.946%)
Market Cap: £694.01m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Statement re High Court decision on LSE data

15 May 2020 10:30

RNS Number : 0599N
Burford Capital Limited
15 May 2020
 

 

 

15 May 2020

 

 

BURFORD CAPITAL STATEMENT ON HIGH COURT DECISION ON ACCESS TO LSE TRADING DATA

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and asset management firm focused on law, today released the following statement concerning the High Court's 104-page decision denying its application to obtain trading data from the London Stock Exchange.

 

Burford has previously recounted its efforts to pursue claims for market manipulation following the August 2019 short attack against its shares. Burford retained a leading expert in the area of market manipulation, Professor Joshua Mitts of Columbia University, who was accepted by the Court as an expert whose work has also been presented to the US Securities and Exchange Commission and in other fora.

 

Unfortunately, the Court, while acknowledging that Professor Mitts had presented expert analysis in which he opined "that market manipulation in the form of spoofing and layering caused an artificial decline in Burford's share price", decided that his conclusions were "speculative". The Court held: "In my judgment, the fully true statement is that it is impossible to determine from the data Prof Mitts reviewed whether any Share Order Events were or may have been manipulative; and any claim that there was market manipulation on 6 or 7 August 2019 by reference to Prof Mitts' data analysis is speculative." Of course, this is the conundrum: Without the trading data sought by Burford, it is impossible to prove market manipulation, which is why Burford brought its application in the first place on the basis of Professor Mitts' extensive expert analyses, which are available on Burford's website.

 

To be clear, the Court did not decide whether or not market manipulation had occurred. That was not its function nor the purpose of the proceeding.

 

The Court also held that even had it not concluded that Professor Mitts' expert evidence was speculative, it still would not have granted relief for a variety of policy reasons, including "a risk of damage to public confidence in the FCA as regulator".

 

Burford's goal in this proceeding was to obtain access to the information needed to assist shareholders in bringing claims for market manipulation, which Burford continues to believe occurred. Without that information, Burford is unfortunately not in a position to advance shareholder claims further. While Burford believes the Court's judgment is flawed as a matter of law and deprives shareholders of redress, there is also a limit to the level of effort that it is sensible and appropriate for Burford to expend, and thus Burford does not intend to appeal the Court's ruling.

 

 

For further information, please contact:

 

Burford Capital Limited

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations - email

 

+44 (0)20 3530 2023

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

Alex Reynolds

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

Jonathan Abbott

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRASFISUIESSEFI
Date   Source Headline
15th Aug 20193:38 pmRNSStatement re Governance Changes
14th Aug 20198:51 amRNSNotification of transactions by PDMRs
13th Aug 20197:00 amRNSNotification of transactions by PDMRs
12th Aug 20197:00 amRNSNotification of transactions by PDMRs
12th Aug 20197:00 amRNSEvidence Of Market Manipulation In Burford Shares
9th Aug 20197:00 amRNSNotification of transactions by PDMRs
8th Aug 20194:02 pmRNSNotification of transactions by PDMRs
8th Aug 20192:04 pmRNSInvestor And Analyst Call Registration Details
8th Aug 201912:45 pmRNSResponse To Short Attack
7th Aug 20193:30 pmRNSReport Critique Meritless, Principals to Buy Stock
7th Aug 20199:21 amRNSStatement re US Research Firm Document
7th Aug 20197:00 amRNSStatement re Share Price Movement
5th Aug 20199:40 amEQSHardman & Co Research: Burford Capital (BUR) Results don't need to be appealed
2nd Aug 20194:04 pmRNSNotification of transactions by PDMRs
25th Jul 20197:00 amRNSInterim Results for six months ended 30 June 2019
11th Jul 20192:30 pmRNSNotice of 1H19 Earnings Call Registration Details
9th Jul 201911:17 amEQSHardman & Co Research: Burford Capital (BUR): Petersen appeals to investors
27th Jun 20192:30 pmRNSNotice of 1H19 Results & Earnings Call
24th Jun 20192:37 pmRNSSupreme Ct Hearing Denial, Petersen Interests Sale
4th Jun 20193:00 pmRNS2018 Sterling Final Div FX Rate
30th May 20197:00 amRNSBurford sees successful end to Teinver annulment
14th May 20192:41 pmRNSResult of AGM
1st May 20196:08 pmRNSTR1 - Notification of Major Holdings
8th Apr 20199:30 amRNS$300m post-settlement investment fund close
15th Mar 20195:10 pmRNSNotification of transactions by PDMRs
13th Mar 20197:00 amRNSFull Year Results 2018
5th Mar 20191:39 pmRNSTR1 - Notification of Major Holdings
27th Feb 20193:00 pmRNSNotice of FY18 Earnings Call Registration Details
9th Jan 20193:00 pmRNSNotice of FY18 Results & Earnings Call
4th Jan 20194:01 pmRNSTR1 - Notification of Major Holdings
3rd Jan 201910:30 amEQSHardman & Co Research: Burford Capital (BUR): Next $1.6bn of investments to boost returns
19th Dec 20187:00 amRNSUpdate on Funding For $1.6 Billion New Investments
19th Nov 20184:36 pmRNSSterling FX Rate for Interim 2018 Dividend
12th Nov 20187:00 amRNSStatement Re Capital Markets Event
5th Nov 20189:30 amRNSDoc re. Capital Markets Event
17th Oct 20182:00 pmRNSBurford Capital's 2018 Litigation Finance Survey
5th Oct 201812:33 pmRNSTR1 - Notification of Major Holdings
5th Oct 20189:58 amEQSHardman & Co Research: Burford Capital (BUR): Equity issue ensures growth is not adjourned
2nd Oct 20187:00 amRNSIssue of Equity
1st Oct 20184:42 pmRNSIssue of Equity
8th Aug 20181:45 pmRNSTR1 - Notification of Major Holdings
27th Jul 20185:26 pmRNSNotification of transactions by PDMRs
27th Jul 20183:00 pmRNSNotification of transactions by PDMRs
26th Jul 20189:45 amEQSHardman & Co Research: Burford Capital (BUR): No need to appeal these results
25th Jul 20183:43 pmRNSTR1 - Notification of Major Holdings
25th Jul 20187:00 amRNSInterim Results for six months ended 30 June 2018
13th Jul 20182:55 pmEQSHardman & Co Research: Burford Capital (BUR): Positive progress on Petersen
12th Jul 20182:48 pmRNSNotice of Interim 2018 Results & Conference Call
11th Jul 20187:00 amRNSUpdate re Successful Petersen Appeal Court Result
3rd Jul 201810:00 amRNSTR-1 Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.